Amgen ‘Remains Committed’ to $27.8B Horizon Acquisition After FTC Challenge

Amgen and Horizon Therapeutics are gearing up for a fight after the Federal Trade Commission sued Tuesday to block the California-based biopharma giant from closing a $27.8 billion deal to acquire Ireland-based Horizon.